Impact of delisting melatonin from a health-system formulary on psychotropic utilization.

Saved in:
Bibliographic Details
Title: Impact of delisting melatonin from a health-system formulary on psychotropic utilization.
Authors: Chan RRD; Alberta Health Services, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada., Nickonchuk T; Alberta Health Services, Peace River, AB, Canada., Jabbal R; Alberta Health Services, Calgary, AB, Canada., Cheng W; Alberta Health Services, Edmonton, AB, Canada., Guirguis M; Alberta Health Services, Edmonton, AB, Canada.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
Source: Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists [Australas Psychiatry] 2026 Apr 28, pp. 10398562261446491. Date of Electronic Publication: 2026 Apr 28.
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 9613603 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1665 (Electronic) Linking ISSN: 10398562 NLM ISO Abbreviation: Australas Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1440-1665
DOI:10.1177/10398562261446491